The California state legislature on Monday (Aug. 31) passed a bill to lower prescription drug costs by allowing the state to develop its own line of generic drugs, including biosimilars of insulin. If signed by Democratic Gov. Gavin Newsom, California would be the first state to directly compete with major pharmaceutical companies. The California Affordable Drug Manufacturing Act of 2020 (SB 852) , would direct the state health agency to partner with drug companies by January to eventually make or...